Table 2 Mean score value of the EORTC QLQ-C30 and EORTC QLQ-BR23 Scales Variables of patients with Breast cancer at TASH, Addis Ababa, Ethiopia
|  | EORTC QLQ-C30 and EORTC QLQ-BR23 Scales | Mean ± SD |
|---|---|---|
EORTC QLQ- C30 | GQoL | 59.32 ± 22.94 |
Functional scales | ||
 Physical functioning | 67.97 ± 25.15 | |
 Role functioning | 73.18 ± 36.19 | |
 Emotional functioning | 71.51 ± 29.74 | |
 Cognitive functioning | 78.55 ± 26.23 | |
 Social functioning | 80.07 ± 30.08 | |
Symptom scales and Items | ||
 Fatigue | 42.38 ± 33.35 | |
 Nausea and Vomiting | 14.48 ± 24.96 | |
 Pain | 36.46 ± 32.91 | |
 Dyspnoea | 18.65 ± 30.69 | |
 Insomnia | 33.16 ± 39.85 | |
 Appetite loss | 36.47 ± 40.69 | |
 Constipation | 24.83 ± 35.72 | |
 Diarrhea | 4.04 ± 14.76 | |
 Financial Difficulties | 48.59 ± 44.56 | |
EORTC QLQ-BR23 | Functional scales | |
 Body image | 77.21 ± 32.09 | |
 Sexual functioning | 17.78 ± 28.09 | |
 Sexual enjoyment | 63.51 ± 30.98 | |
 Future perspective | 52.47 ± 43.13 | |
Symptom scales/items | ||
 Systemic therapy side effects | 34.11 ± 22.59 | |
 Breast symptoms | 18.39 ± 22.71 | |
 Arm symptoms | 24.92 ± 25.06 | |
 Upset by hair loss | 26.92 ± 40.24 | |